Review of influential clinical factors in reducing the risk of unsuccessful MRI-guided HIFU treatment outcome of uterine fibroids

Magnetic resonance imaging-guided high-intensity focused ultrasound (MRI-guided HIFU) is an effective noninvasive treatment option for symptomatic uterine fibroids. However, tissue characteristics of uterine fibroids and technical limitations can limit the patient population that can benefit from this therapy. In this article, we present our literature review focusing on the influential clinical factors that might reduce the risk of an unsuccessful MRI-guided HIFU treatment outcome of uterine fibroids.

___

1. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003; 188:100–107. [CrossRef]

2. Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril 2009; 91:1215–1223. [CrossRef]

3. Stewart EA, Gedroyc WM, Tempany CM, et al. Focused ultrasound treatment of uterine fibroid tumors: Safety and feasibility of a noninvasive thermoablative technique. Am J Obstet Gynecol 2003; 189:48–54. [CrossRef]

4. Funaki K, Fukunishi H, Funaki T, Sawada K, Kaji Y, Maruo T. Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of preexisting T2 weighted magnetic resonance images. Am J Obstet Gynecol 2007; 196:184.e1–6. [CrossRef ]

5. Stewart EA, Gostout B, Rabinovici J, Kim HS, Regan L, Tempany CM. Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol 2007; 110:279–287. [CrossRef]

6. Lenard ZM, McDannold NJ, Fennessy FM, et al. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery-imaging predictors of success. Radiology 2008; 249:187–194. [CrossRef]

7. Kim YS, Kim JH, Rhim H, et al. Volumetric MR-guided high-intensity focused ultrasound ablation with a one-layer strategy to treat large uterine fibroids: initial clinical outcomes. Radiology 2012; 263:600–609. [CrossRef]

8. Yoon SW, Lee C, Kim KA, et al. Patient selection guidelines in MR-guided high-intensity focused ultrasound surgery of uterine fibroids: a pictorial guide to relevant findings in screening pelvic MRI. Eur Radiol 2008; 18:2997–3006. [CrossRef]

9. Behera MA, Leong M, Johnson L, Brown H. Eligibility and accessibility of magnetic resonance- guided focused ultrasound (MRgFUS) for the treatment of uterine leiomyomas. Fertil Steril 2010; 94:1864–1868. [CrossRef]

10. Arleo EK, Khilnani NM, Ng A, Min RJ. Features influencing patient selection for fibroid treatment with magnetic resonance-guided focused ultrasound. J Vasc Interv Radiol 2007; 18:681–685. [CrossRef]

11. Pron G. Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) Treatment of Symptomatic Uterine Fibroids: An Evidence-Based Analysis. Ont Health Technol Assess Ser 2015; 15:1–86.

12. Zhao W P, Chen J Y, Zhang L, et al. Feasibility of ultrasound-guided high intensity focused ultrasound ablating uterine fibroids with hyperintense on T2-weighted MR imaging. Eur J Radiol 2013; 82:e43–49. [CrossRef]

13. Mikami K, Murakami T, Okada A, Osuga K, Tomoda K, Nakamura H. Magnetic resonance imaging-guided focused ultrasound ablation of uterine fibroids: early clinical experience. Radiat Med 2008; 26:198–205. [CrossRef]

14. Yoon SW, Lee C, Kim KA, Kim SH. Contrast enhanced dynamic MR imaging of uterine fibroids as a potential predictor of patient eligibility for MR guided focused ultrasound (MRgFUS) treatment for symptomatic uterine fibroids. Obstet Gynecol Int 2010; 834275:1–4. [CrossRef]

15. Mindjuk I, Trumm CG, Herzog P, Stahl R, Matzko M. MRI predictors of clinical success in MR-guided focused ultrasound (MRgFUS) treatments of uterine fibroids: results from a single centre. Eur Radiol 2015; 25:1317–1328. [CrossRef]

16. Kim YS, Lim HK, Kim JH, et al. Dynamic contrast- enhanced magnetic resonance imaging predicts immediate therapeutic response of magnetic resonance–guided high-intensity focused ultrasound ablation of symptomatic uterine fibroids. Invest Radiol 2011; 46:639– 647. [CrossRef]

17. Liu J, Keserci B, Yang X, et al. Volume transfer constant (Ktrans) maps from dynamic contrast enhanced MRI as potential guidance for MR-guided high intensity focused ultrasound treatment of hypervascular uterine fibroids. Magn Reson Imaging 2014; 32:1156–1161. [CrossRef]

18. Kim YS, Kim BG, Rhim H, et al. Uterine fibroids: semiquantitative perfusion MR imaging parameters associated with the intra-procedural and immediate postprocedural treatment efficiencies of MR imaging-guided high-intensity focused ultrasound ablation. Radiology 2014; 273:462–471. [CrossRef]

19. Wei C, Fang X, Wang CB, Chen Y, Xu X, Dong JN. The predictive value of quantitative DCE metrics for immediate therapeutic response of high intensity focused ultrasound ablation (HIFU) of symptomatic uterine fibroids. Abdom Radiol 2018; 43:2169–2175.

20. Keserci B, Nguyen D. The role of T1 perfusion- based classification in magnetic resonance- guided high-intensity focused ultrasound ablation of uterine fibroids. Eur Radiol 2017; 27:5299–5308. [CrossRef]

21. Keserci B, Nguyen D. Magnetic resonance imaging parameters in predicting the treatment outcome of high-intensity focused ultrasound ablation of uterine fibroids with an immediate nonperfused volume ratio of at least 90%. Acad Radiol 2018 [E-pub ahead of print]. [CrossRef]

22. Pennes HH. Analysis of tissue and arterial blood temperatures in the resting human forearm. J Appl Physiol 1948; 1:93–122. [CrossRef]

23. Zaher S, Gedroyc WM, Regan L. Patient suitability for magnetic resonance guided focused ultrasound surgery of uterine fibroids. Eur J Obstet Gynecol Reprod Biol 2009; 143:98–102. [CrossRef]

24. Katsumori T, Akazawa K, Mihara T. Uterine artery embolization for pedunculated subserosal fibroids. AJR Am J Roentgenol 2005; 184:399– 402. [CrossRef]

25. Smeets AJ, Nijenhuis RJ, Boekkooi PF, et al. Safety and effectiveness of uterine artery embolization in patients with pedunculated fibroids. J Vasc Interv Radiol 2009; 20:1172– 1175. [CrossRef]

26. Park H, Yoon SW, Kim KA, Jung KD, Jung SG. Magnetic resonance imaging–guided focused ultrasound treatment of pedunculated subserosal uterine fibroids: a preliminary report. J Vasc Interv Radiol 2012; 23:1589–1593. [CrossRef]

27. Filipowska J, Łoziński T. Magnetic resonance- guided high-intensity focused ultrasound (MR-HIFU) in treatment of symptomatic uterine myomas. Pol J Radiol 2014; 79:439–443. [CrossRef]

28. Kim YS, Kim TJ, Lim HK, et al. Preservation of the endometrial enhancement after magnetic resonance imaging-guided high-intensity focused ultrasound ablation of submucosal uterine fibroids. Eur Radiol 2017; 27:3956–3965. [CrossRef]

29. Froling V, Kroncke TJ, Schreiter NF, et al. Technical eligibility for treatment of magnetic resonance- guided focused ultrasound surgery. Cardiovasc Intervent Radiol 2014; 37:445– 450. [CrossRef]

30. Köhler MO, Mougenot C, Quesson B, et al. Volumetric HIFU ablation under 3D guidance of rapid MRI thermometry. Med Phys 2009; 36:3521–3535. [CrossRef]

31. Kim YS, Keserci B, Partanen A, et al. Volumetric MR-HIFU ablation of uterine fibroids: role of treatment cell size in the improvement of energy efficiency. Eur J Radiol 2012; 81:3652–3659. [CrossRef]

32. Smart OC, Hindley JT, Regan L, Gedroyc WM. Magnetic resonance guided focused ultrasound surgery of uterine fibroids: the tissue effects of GnRH agonist pre-treatment. Eur Radiol 2006; 59:163–167. [CrossRef]

33. Trumm CG, Stahl R, Clevert DA, et al. Magnetic resonance imaging-guided focused ultrasound treatment of symptomatic uterine fibroids: impact of technology advancement on ablation volumes in 115 patients. Invest Radiol 2013; 48:359–365. [CrossRef]

34. Huang X, He M, Liu YJ, Zhang L, Wang ZB. Effect of oxytocin on uterine fibroids treated by ultrasound ablation (in Chinese). Zhonghua Fu Chan Ke Za Zhi 2011; 46:412–415.

35. Kim YS, Bae DS, Park MJ, et al. Techniques to expand patient selection for MRI-guided high-intensity focused ultrasound ablation of uterine fibroids. AJR Am J Roentgenol 2014; 202:443– 451. [CrossRef]

36. Zaher S, Gedroyc W, Lyons D, Regan L. A novel method to aid in the visualization and treatment of uterine fibroids with MRgFUS in patients with abdominal scars. Eur J Radiol 2010; 76:269–273. [CrossRef]

37. Gorny KR, Chen S, Hangiandreou NJ, et al. Initial evaluation of acoustic reflectors for the preservation of sensitive abdominal skin areas during MRgFUS treatment. Phys Med Biol 2009; 54:N125–133.

38. Yoon SW, Seong SJ, Jung SG, Lee SY, Jun HS, Lee JT. Mitigation of abdominal scars during MR-guided high-intensity focused ultrasound treatment of uterine leiomyomas with the use of an energy-blocking scar patch. J Vasc Interv Radiol 2011; 22:1747–1750. [CrossRef]

39. Zhu Y, Keserci B, Viitala A, Wei J, Yang X, Wang X. Volumetric MR-guided high-intensity focused ultrasound ablation to treat uterine fibroids through the abdominal scars using scar patch: a case report. J Ther Ultrasound 2016; 4:20. [CrossRef]

40. Keserci B, Nguyen D. Volumetric magnetic resonance-guided high-intensity focused ultrasound ablation of uterine fibroids through abdominal scars: the impact of a scar patch on therapeutic efficacy and adverse effects. J Ther Ultrasound 2017; 5:22. [CrossRef]

41. Henriques FC, Moritz AR. Studies of thermal injury in the conduction of heat to and through skin and the temperatures attained therein: A theoretical and experimental investigation. Am J Pathol 1947; 23:531–549.

42. Anderson GS. Human morphology and temperature regulation. Int J Biometeorol 1999; 43:99–109. [CrossRef]

43. Cohen ML. Measurement of the thermal properties of human skin. A review. J Invest Dermatol 1977; 69:333–338. [CrossRef]

44. Heinonen I, Kemppainen J, Kaskinoro K, Knuuti J, Boushel R, Kalliokoski KK. Capacity and hypoxic response of subcutaneous adipose tissue blood flow in humans. Circ J 2014; 78:1501– 1506. [CrossRef]

45. Chen R, Keserci B, Bi H, et al. The safety and effectiveness of volumetric magnetic resonance- guided high intensity focused ultrasound treatment of symptomatic uterine fibroids: Early clinical experience in China. J Ther Ultrasound 2016; 4:27. [CrossRef]

46. Peng S, Zhang L, Hu L, et al. Factors influencing the dosimetry for high-intensity focused ultrasound ablation of uterine fibroids: a retrospective study. Medicine 2015; 94:1–10. [CrossRef]

47. Liu Z, Gong C, Liu Y, Zhang L. Establishment of a scoring system for predicting the difficulty level of high-intensity focused ultrasound ablation of uterine fibroids. Int J Hyperthermia 2018; 34:77–86. [CrossRef]

48. Hesley GK, Felmlee JP, Gebhart JB, et al. Noninvasive treatment of uterine fibroids: early Mayo Clinic experience with magnetic resonance imaging- guided focused ultrasound. Mayo Clin Proc 2006; 81:936–942. [CrossRef]

49. Nyapathy V, Polina L. MRgFUS treatment of uterine fibroid in a nulliparous woman with acute retention of urine. J Radiol Case Rep 2012; 6:1–8. [CrossRef]

50. Park MJ, Kim YS, Rhim H, Lim HK. Technique to displace bowel loops in MRI-guided high-intensity focused ultrasound ablation of fibroids in the anteverted or anteflexed uterus. AJR Am J Roentgenol 2013; 201:W761–764. [CrossRef]

51. Kim YS, Lim HK, Rhim H. Magnetic resonance imaging-guided high-intensity focused ultrasound ablation of uterine fibroids: effect of bowel interposition on procedure feasibility and a unique bowel displacement technique. PloS ONE 2016; 11:1–14. [CrossRef]

52. Jeong JH, Hong GP, Kim YR, Ha JE, Lee KS. Usefulness of modified BRB technique in treatment to ablate uterine fibroids with magnetic resonance image-guided high intensity focused ultrasound. Obstet Gynecol Sci 2017; 60:92–99. [CrossRef]

___

Diagnostic and Interventional Radiology
  • ISSN: 1305-3612
  • Yayın Aralığı: Yılda 6 Sayı
  • Başlangıç: 2001
  • Yayıncı: AVES Yayıncılık

9.9b6b

Sayıdaki Diğer Makaleler

Prone transradial catheterization for combined single-session endovascular and percutaneous interventions: approach, technical success, safety, and outcomes in 15 patients

Rajiv N. SRİNİVASA, Jeffrey Forris Beecham CHİCK, Joseph J. GEMMETE, Bill S. MAJDALANY, Anthony HAGE, Alex JO, Ravi N. SRİNİVASA

Impact on genitourinary function and quality of life following focal irreversible electroporation of different prostate segments

Matthijs J. SCHELTEMA, John I. CHANG, Willemien van den BOS, Ilan GİELCHİNSKY, Tuan V. NGUYEN, Theo M. de REİJKE, Amila R. SİRİWARDANA, Maret BÖHM, Jean J. de la ROSETTE, Phillip D. STRİCKER

Reliability of measuring the fat content of the lumbar vertebral marrow and paraspinal muscles using MRI mDIXON-Quant sequence

Yong ZHANG, Zhuang ZHOU, Chao WANG, Xiaoguang CHENG, Ling WANG, Yangyang DUANMU, Chenxin ZHANG, Nicola VERONESE, Giuseppe GUGLİELMİ

Review of influential clinical factors in reducing the risk of unsuccessful MRI-guided HIFU treatment outcome of uterine fibroids

Nguyen Minh DUC, Bilgin KESERCİ

Emergent stent-graft repair of a massive aortic pseudoaneurysm secondary to Behçet’s disease in a child

Allison DAWSON, Giri M. SHİVARAM, Sarah K. BAXTER, Eric J. MONROE, Kevin S. H. KOO

Coil-assisted retrograde transvenous obliteration for the treatment of duodenal varix

Shin Jae LEE, Gyeong Sik JEON

Incidental bladder cancers found on multiparametric MRI of the prostate gland: a single center experience

Kareem N. RAYN, Graham HALE, Jonathon BLOOM, Samuel GOLD, Filipe L.F. CARVALHO, Sherif MERALIVAND, Marcin CZARNİECKİ, Bradford J. WOOD, Maria J. MERİNO, peter L. CHOYKE, Barış TÜRKBEY, Peter A. PINTO, Piyush K. AGARWAL

Imaging features of bile duct adenoma: case series and review of literature

Jeffrey A. CHUY, Ishan GARG, Rondell P. GRAHAM, Wendaline M. VANBUREN, Sudhakar K. VENKATESH

Problem-solving breast MRI: useful or a source of new problems?

Füsun TAŞKIN, Yasemin Durum POLAT, İbrahim H. ERDOĞDU, Figen T. TÜRKDOĞAN, Veli Suha ÖZTÜRK, Serdar ÖZBAŞ

Clearlumen-II thrombectomy system for treatment of acute lower limb ischemia with underlying chronic occlusive disease

Murat CANYİĞİT, Ömer Faruk ATEŞ, Muhammet Fethi SAĞLAM, Gökhan YUCE